BIO-B
Bio-Rad Laboratories, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+39/100
Last price
365.08
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
365.08
Day high
365.08
Day low
365.08
Volume
8
Market cap
$9.76B
P/E (TTM)
46.27
52W range
244.54 – 365.08
Trailing performance
Returnvs SPY
1W
0.00%
-1.7%
1M
0.00%
-1.3%
3M
+24.44%
+21.2%
6M
+31.80%
+17.0%
YTD
+17.50%
+3.7%
1Y
+28.15%
+12.6%
3Y
+2.82%
-78.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BIO-B open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
26.26M
Total on file
Fundamentals
Market cap$9.76B
Enterprise value$9.51B
Revenue (TTM)$2.59B
Gross profit$1.35B
EBITDA$441.00M
Net income$222.40M
EPS (TTM)$7.89
Free cash flow$283.19M
Total cash$1.62B
Total debt$1.37B
Book value / share$268.30
Shares outstanding5.06M
Float21.35M
Short % of float0.00%
Dividend yield0.00%
Beta (5Y)1.07
Valuation & profitability ratios
Trailing P/E46.27
Forward P/E—
PEG ratio4.23
Price / sales—
Price / book1.36
EV / revenue3.67
EV / EBITDA21.57
Gross margin52.04%
Operating margin11.18%
Profit margin8.59%
Return on equity3.11%
Return on assets1.66%
Debt / equity19.10
Current ratio3.14
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.58B | $2.57B | $2.67B | $2.80B | +0.7% |
| Operating revenue | $2.58B | $2.57B | $2.67B | $2.80B | +0.7% |
| Cost of revenue | $1.24B | $1.19B | $1.24B | $1.23B | +4.7% |
| Gross profit | $1.34B | $1.38B | $1.43B | $1.57B | -2.8% |
| Research & development | $275.60M | $295.90M | $247.40M | $256.90M | -6.9% |
| Selling, general & admin | $844.30M | $814.00M | $841.70M | $827.80M | +3.7% |
| Total operating expense | $1.12B | $1.11B | $1.09B | $1.09B | +1.0% |
| Operating income | $218.60M | $269.00M | $337.80M | $475.10M | -18.7% |
| Net interest income | $46.50M | $33.10M | $51.50M | $20.00M | +40.5% |
| Pre-tax income | $995.50M | -$2.34B | -$850.10M | -$4.70B | +142.5% |
| Tax provision | $235.60M | -$498.30M | -$212.80M | -$1.08B | +147.3% |
| Net income | $759.90M | -$1.84B | -$637.30M | -$3.63B | +141.2% |
| Net income to common | $759.90M | -$1.84B | -$637.30M | -$3.63B | +141.2% |
| Basic EPS | 27.87 | -65.36 | -21.82 | -121.79 | +142.6% |
| Diluted EPS | 27.85 | -65.36 | -21.82 | -121.79 | +142.6% |
| EBIT | $1.04B | -$2.29B | -$800.70M | -$4.67B | +145.5% |
| EBITDA | $1.21B | -$2.14B | -$654.80M | -$4.53B | +156.5% |
| Basic shares | 27.26M | 28.21M | 29.21M | 29.79M | -3.4% |
| Diluted shares | 27.28M | 28.21M | 29.21M | 29.79M | -3.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $529.80M | $488.10M | $403.80M | $434.21M | +8.5% |
| Cash & short-term investments | $1.54B | $1.66B | $1.61B | $1.79B | -7.4% |
| Accounts receivable | $460.60M | $452.50M | $489.00M | $494.64M | +1.8% |
| Inventory | $740.70M | $760.00M | $780.50M | $719.32M | -2.5% |
| Total current assets | $2.91B | $3.03B | $3.05B | $3.16B | -4.1% |
| Property, plant & equipment | $709.90M | $688.60M | $723.70M | $679.55M | +3.1% |
| Goodwill & intangibles | $754.10M | $704.10M | $734.10M | $738.60M | +7.1% |
| Total assets | $10.58B | $9.36B | $12.30B | $13.50B | +12.9% |
| Total current liabilities | $517.00M | $467.80M | $522.80M | $568.71M | +10.5% |
| Current debt | $1.30M | $1.20M | $500.00K | $465.00K | +8.3% |
| Long-term debt | $1.20B | $1.20B | $1.20B | $1.20B | +0.2% |
| Total debt | $1.39B | $1.37B | $1.41B | $1.39B | +0.8% |
| Total liabilities | $3.12B | $2.79B | $3.56B | $3.89B | +11.7% |
| Retained earnings | $8.18B | $7.42B | $9.26B | $9.90B | +10.2% |
| Shareholder equity | $7.45B | $6.57B | $8.74B | $9.62B | +13.5% |
| Working capital | $2.39B | $2.56B | $2.53B | $2.59B | -6.8% |
| Net tangible assets | $6.70B | $5.87B | $8.01B | $8.88B | +14.2% |
| Shares issued | 30.27M | 30.27M | 30.27M | 30.24M | -0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $759.90M | -$1.84B | -$637.30M | -$3.63B | +141.2% |
| Depreciation & amortisation | $165.40M | $151.60M | $145.90M | $137.30M | +9.1% |
| Stock-based compensation | $58.00M | $62.30M | $61.30M | $60.90M | -6.9% |
| Change in working capital | $272.40M | -$620.80M | -$432.80M | -$1.61B | +143.9% |
| Operating cash flow | $532.20M | $455.20M | $374.90M | $194.40M | +16.9% |
| Capital expenditure | -$157.60M | -$189.00M | -$156.70M | -$114.30M | +16.6% |
| Investing cash flow | -$189.70M | -$160.20M | $20.20M | -$1.21B | -18.4% |
| Share buybacks | -$295.50M | -$203.60M | -$428.70M | -$215.70M | -45.1% |
| Financing cash flow | -$283.20M | -$218.80M | -$425.60M | $973.60M | -29.4% |
| Free cash flow | $374.60M | $266.20M | $218.20M | $80.10M | +40.7% |
| End cash position | $532.20M | $489.80M | $404.40M | $434.50M | +8.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $651.00M | $592.10M | $693.20M | $653.00M | $651.60M | — | +9.9% |
| Operating revenue | $651.00M | $592.10M | $693.20M | $653.00M | $651.60M | — | +9.9% |
| Cost of revenue | $305.20M | $282.70M | $348.00M | $309.60M | $306.30M | — | +8.0% |
| Gross profit | $345.80M | $309.40M | $345.20M | $343.40M | $345.30M | — | +11.8% |
| Research & development | $61.20M | $62.90M | $70.30M | $71.30M | $60.50M | — | -2.7% |
| Selling, general & admin | $212.00M | $212.40M | $221.00M | $206.80M | $207.70M | — | -0.2% |
| Total operating expense | $273.20M | $275.30M | $291.30M | $279.50M | $268.20M | — | -0.8% |
| Operating income | $72.60M | $34.10M | $53.90M | $63.90M | $77.10M | — | +112.9% |
| Net interest income | $10.20M | $8.70M | $18.90M | $1.40M | $2.10M | — | +17.2% |
| Pre-tax income | $542.10M | -$689.80M | $929.20M | -$431.10M | $414.00M | — | +178.6% |
| Tax provision | $170.70M | -$162.70M | $209.20M | -$89.20M | $96.20M | — | +204.9% |
| Net income | $371.40M | -$527.10M | $720.00M | -$341.90M | $317.80M | — | +170.5% |
| Net income to common | $371.40M | -$527.10M | $720.00M | -$341.90M | $317.80M | — | +170.5% |
| Basic EPS | 13.89 | -19.55 | 26.69 | — | 11.67 | 2.29 | +171.0% |
| Diluted EPS | 13.85 | -19.55 | 26.65 | — | 11.67 | 2.29 | +170.8% |
| EBIT | $554.20M | -$677.50M | $941.30M | -$418.80M | $426.60M | — | +181.8% |
| EBITDA | $595.30M | -$636.60M | $983.80M | -$374.60M | $467.20M | — | +193.5% |
| Basic shares | 26.75M | 26.96M | 26.98M | — | 27.23M | 27.94M | -0.8% |
| Diluted shares | 26.81M | 26.96M | 27.01M | — | 27.23M | 27.95M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $517.00M | $507.20M | $529.80M | $395.80M | $369.30M | +1.9% |
| Cash & short-term investments | $1.62B | $1.56B | $1.54B | $1.42B | $1.37B | +3.4% |
| Accounts receivable | $441.80M | $426.20M | $460.60M | $464.70M | $469.90M | +3.7% |
| Inventory | $780.60M | $770.50M | $740.70M | $783.20M | $798.80M | +1.3% |
| Total current assets | $3.02B | $2.94B | $2.91B | $2.84B | $2.81B | +2.7% |
| Property, plant & equipment | $671.90M | $689.40M | $709.90M | $720.50M | $740.10M | -2.5% |
| Goodwill & intangibles | $734.30M | $743.90M | $754.10M | $967.10M | $978.50M | -1.3% |
| Total assets | $10.25B | $9.79B | $10.58B | $9.70B | $10.21B | +4.7% |
| Total current liabilities | $961.30M | $917.00M | $517.00M | $522.30M | $548.90M | +4.8% |
| Current debt | $400.70M | $400.50M | $1.30M | $1.30M | $1.30M | +0.0% |
| Long-term debt | $803.00M | $802.90M | $1.20B | $1.20B | $1.20B | +0.0% |
| Total debt | $1.37B | $1.38B | $1.39B | $1.40B | $1.41B | -0.6% |
| Total liabilities | $3.08B | $2.94B | $3.12B | $2.96B | $3.09B | +4.7% |
| Retained earnings | $8.02B | $7.65B | $8.18B | $7.46B | $7.80B | +4.9% |
| Shareholder equity | $7.17B | $6.85B | $7.45B | $6.74B | $7.13B | +4.7% |
| Working capital | $2.06B | $2.03B | $2.39B | $2.32B | $2.26B | +1.7% |
| Net tangible assets | $6.44B | $6.11B | $6.70B | $5.77B | $6.15B | +5.4% |
| Shares issued | 26.74M | 30.27M | 30.27M | 30.27M | 30.27M | -11.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $371.40M | -$527.10M | $720.00M | -$341.90M | $317.80M | +170.5% |
| Depreciation & amortisation | $41.10M | $40.90M | $42.50M | $44.20M | $40.60M | +0.5% |
| Stock-based compensation | $14.50M | $15.00M | $15.90M | $14.90M | $11.90M | -3.3% |
| Change in working capital | $138.40M | -$168.50M | $254.10M | -$102.40M | $77.10M | +182.1% |
| Operating cash flow | $98.70M | $108.10M | $164.90M | $120.90M | $116.50M | -8.7% |
| Capital expenditure | -$32.00M | -$30.00M | -$45.80M | -$31.70M | -$45.70M | -6.7% |
| Investing cash flow | -$66.70M | -$93.20M | -$34.20M | -$43.00M | -$115.40M | +28.4% |
| Share buybacks | -$31.50M | -$47.80M | $0 | -$53.40M | -$140.20M | +34.1% |
| Financing cash flow | -$27.60M | -$44.00M | $3.30M | -$52.50M | -$136.30M | +37.3% |
| Free cash flow | $66.70M | $78.10M | $119.10M | $89.20M | $70.80M | -14.6% |
| End cash position | $518.80M | $509.00M | $532.20M | $398.20M | $371.70M | +1.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $649.95M | -0.5% |
| Next quarter | — | — | $695.40M | +0.3% |
| Current year | — | — | $2.57B | -0.5% |
| Next year | — | — | $2.62B | +2.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders98.23%
Held by institutions0.04%
Institutions holding7
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
365.08
+0.00% from price
SMA 20
365.08
0.00% from price
SMA 50
353.32
+3.33% from price
SMA 100
325.13
+12.29% from price
SMA 200
305.90
+19.35% from price
EMA 12
364.95
+0.03% from price
EMA 26
361.94
+0.87% from price
EMA 50
351.70
+3.80% from price
RSI (14)
97.2
Overbought
MACD (12,26,9)
3.01
Hist -1.18
ATR (14)
0.00
—
Realised vol 30D
0.0%
Annualised
Bollinger upper
365.08
20, 2σ
Bollinger lower
365.08
20, 2σ
50 / 200 cross
Golden
353.32 vs 305.90
Trend bias
Above 200
+19.35%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.05
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
0.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-20.4%
Peak to trough
Max drawdown 5Y
-71.3%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
1.07
5Y monthly, from filing
Short interest
Shares short
2
Prior 31
Change vs prior
-93.5%
Shorts covering
% of float
0.00%
Normal
% of shares out
0.00%
Against total outstanding
Days to cover
1.0
Liquid
Float
21.35M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateMar 8, 2002
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.